Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon

IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Value in health regional issues Pub Date : 2024-02-09 DOI:10.1016/j.vhri.2023.12.008
Samer A. Kharroubi PhD , Clara Mukuria PhD , Dalia Dawoud PhD , Donna Rowen PhD
{"title":"Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon","authors":"Samer A. Kharroubi PhD ,&nbsp;Clara Mukuria PhD ,&nbsp;Dalia Dawoud PhD ,&nbsp;Donna Rowen PhD","doi":"10.1016/j.vhri.2023.12.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The SF-6Dv1 is a preference-based measure derived from the SF-36 for use in quality-adjusted life-year estimation for cost-utility analysis. Country-specific value sets for SF-6Dv1 are needed to reflect societal preferences but none are available for Lebanon and other Arabic countries. This study aimed to generate a value set for SF-6Dv1 for Lebanon and to compare results with the UK set.</p></div><div><h3>Methods</h3><p>A sample of 249 health states defined by the SF-6Dv1 were valued by a representative sample of 577 members of the Lebanon general population, using standard gamble. Several multivariate regression models at mean and individual level were fitted to estimate utilities for all SF-6Dv1 states with selection of best fitting models based on predictive ability, consistency, and model fit. The best fitting models were compared with those fitted in the UK study.</p></div><div><h3>Results</h3><p>Data from 553 eligible respondents providing 3308 valuations were used for the analysis. Lebanese values were consistently higher than UK values, indicating differences in preferences, and there were no negative values. The random effects model using only main effects was the best performing model. There were inconsistencies in 2 dimensions, thereby consistent models were estimated with values ranging from 0.367 to 1. The results are consistent with the UK results.</p></div><div><h3>Conclusions</h3><p>This study provides the first population-based value set for SF-6Dv1 health states for Lebanon, making it possible to generate quality-adjusted life-years for cost-utility analysis studies. The potential for applications of a standardized utility measure is enormous both in Lebanon and all Arab countries.</p></div>","PeriodicalId":23497,"journal":{"name":"Value in health regional issues","volume":"42 ","pages":"Pages 1-10"},"PeriodicalIF":1.4000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in health regional issues","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212109924000049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

The SF-6Dv1 is a preference-based measure derived from the SF-36 for use in quality-adjusted life-year estimation for cost-utility analysis. Country-specific value sets for SF-6Dv1 are needed to reflect societal preferences but none are available for Lebanon and other Arabic countries. This study aimed to generate a value set for SF-6Dv1 for Lebanon and to compare results with the UK set.

Methods

A sample of 249 health states defined by the SF-6Dv1 were valued by a representative sample of 577 members of the Lebanon general population, using standard gamble. Several multivariate regression models at mean and individual level were fitted to estimate utilities for all SF-6Dv1 states with selection of best fitting models based on predictive ability, consistency, and model fit. The best fitting models were compared with those fitted in the UK study.

Results

Data from 553 eligible respondents providing 3308 valuations were used for the analysis. Lebanese values were consistently higher than UK values, indicating differences in preferences, and there were no negative values. The random effects model using only main effects was the best performing model. There were inconsistencies in 2 dimensions, thereby consistent models were estimated with values ranging from 0.367 to 1. The results are consistent with the UK results.

Conclusions

This study provides the first population-based value set for SF-6Dv1 health states for Lebanon, making it possible to generate quality-adjusted life-years for cost-utility analysis studies. The potential for applications of a standardized utility measure is enormous both in Lebanon and all Arab countries.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
估算黎巴嫩人口样本的 SF-6Dv1 值集。
目的:SF-6Dv1 是一种基于偏好的测量方法,源自 SF-36,用于成本效用分析中的质量调整生命年估算。为反映社会偏好,需要针对具体国家的 SF-6Dv1 值集,但黎巴嫩和其他阿拉伯国家尚无此类值集。本研究旨在为黎巴嫩生成 SF-6Dv1 的价值集,并将结果与英国的价值集进行比较:方法:对 SF-6Dv1 中定义的 249 种健康状况进行了抽样调查,调查对象是黎巴嫩具有代表性的 577 名普通民众,调查采用了标准赌博法。根据预测能力、一致性和模型拟合程度,选择最佳拟合模型,对平均水平和个体水平的多个多元回归模型进行拟合,以估算所有 SF-6Dv1 状态的效用。将最佳拟合模型与英国研究中的拟合模型进行比较:分析使用了 553 位符合条件的受访者提供的 3308 个估值数据。黎巴嫩人的估价一直高于英国人,这表明他们的偏好存在差异,而且没有负值。仅使用主效应的随机效应模型是表现最好的模型。在 2 个维度上存在不一致,因此估算出了一致的模型,数值范围在 0.367 到 1 之间:这项研究为黎巴嫩提供了第一套基于人群的 SF-6Dv1 健康状态值,从而为成本效用分析研究提供了质量调整生命年。在黎巴嫩和所有阿拉伯国家,标准化效用测量的应用潜力巨大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Value in health regional issues
Value in health regional issues Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
2.60
自引率
5.00%
发文量
127
期刊最新文献
Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System Valuing an Index of Sanitation-Related Quality of Life in Urban Mozambique: A Discrete Choice Experiment Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology Setting Life With Cystic Fibrosis: The Socioeconomic Impact on Patients and Their Caregivers Cost-Effectiveness Analysis of Pharmacological Treatment With Insulin and Insulin Analogs for Type 1 and Type 2 Diabetes Mellitus in Colombia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1